This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

A look at the use of Veklury and Paxlovid in Pediatric Covid patients

Ticker(s): PFE, GILD

Who's the expert?

Institution: Yale University School of Medicine

  • Associate Professor of Pediatric Emerency Medicine and Director of the Pediatric Diasaster Preparedness Program, an EMS physician, and and Attending Physician at Yale-New Haven Childrens Hospital.
  • designed experiential and didactic curricula in pediatric disaster medicine, and has numerouspublications about triage and prehospital response
  •  treats 60 pediatric patients with SARS-CoV-2 per month and has prescribed Veklury for 65 patients and 10 for Paxlovid

Interview Goal
Discussing the use of Veklury(remdesivir) and Paxlovid in pediatric patients as well as the ongoing Phase 2/3 clinical trial study of Paxlovid for children under the age of 12.

Do you want answers to these questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.